HTA169 Health Technology Assessment and Reimbursement for Select Oncology Therapies in European Major Markets
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1627
https://www.valueinhealthjournal.com/article/S1098-3015(22)03832-3/fulltext
Title :
HTA169 Health Technology Assessment and Reimbursement for Select Oncology Therapies in European Major Markets
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03832-3&doi=10.1016/j.jval.2022.09.1627
First page :
Section Title :
Open access? :
No
Section Order :
11179